France-based biotech Abivax ( ABVX +20.75%) landed on many investors' buy lists on Monday, following a media report that a giant American peer was interested in acquiring it. With that considerable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback